Healio

Icosapent ethyl ‘could have relevance’ for lowering CV risk in adults with CAD on statins

Please provide your email address to receive an email when new articles are posted on . In patients with CAD and low EPA:AA ratio on a statin, icosapent ethyl reduced coronary events. CV events were ...
Healio

‘Possible’ benefit with highly purified EPA to reduce CV risk in CAD with statin therapy

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In Japanese adults with chronic CAD already treated with statin therapy, highly purified ...
MedPage Today

Icosapent Ethyl Linked to Reduced Risk of Cardiovascular Events

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Use of icosapent ethyl (Vascepa), a highly purified ...
TCTMD

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Photo Credit: AHA/Todd Buchanan 2022. Used with permission. CHICAGO, IL—When added to statin therapy, icosapent ethyl, a pharmaceutical-grade omega-3 fatty acid formulation, did not reduce major ...